(1993). "Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy." Breast Cancer Res Treat 25(3): 247-56.Brooks SA, Leathem AJC, Camplejohn RS et al. Markers of prognosis in breast cancer — the relationship ...
Local breast cancer might have a 'non-metastatic, good-prognosis' stem cell of origin; metastasizing systemic breast cancer might have a 'metastatic, poor-prognosis' stem cell of origin. Abstract Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant org...
Local breast cancer might have a 'non-metastatic, good-prognosis' stem cell of origin; metastasizing systemic breast cancer might have a 'metastatic, poor-prognosis' stem cell of origin. Abstract Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant org...
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancerAn Na Seo, Hee Jin Lee, Eun Joo Kim, Min Hye Jang, Yu Jung Kim, Jee Hyun Kim, Sung-Won Kim, Han Suk Ryu, In Ae Park, Seock-Ah Im, ...
In the last few decades, proliferative markers have been broadly evaluated as prognostic and predictive factors for early stage breast cancer patients. Several papers evaluating one or more markers have been published, often with contradictory results. As a consequence, there is still uncertainty about...
The cancer stem cell (CSC) hypothesis states that tumours consist of a cellular hierarchy with CSCs at the apex driving tumour recurrence and metastasis. Hence, CSCs are potentially of profound clinical importance. We set out to establish the clinical relevance of breast CSC markers by profiling ...
Markers for breast cancerCorrelations between polymorphisms and breast cancer are provided. Methods of diagnosing, prognosing, and treating breast cancer are provided. Systems and kits for diagnosis, prognosis and treatment of breast cancer are provided. Methods of identifying breast cancer modulators ...
The present invention relates to genetic markers whose expression is correlated with breast cancer. Specifically, the invention provides sets of markers whose expression patterns ca
2. Normal breast versus (pre)malignant breast tissues: quantity and quality of TILs 3. Prognosis of breast cancer based on TILs 4. Prediction of breast cancer therapies based on TILs 5. Immunogenicity of breast cancer knows several flavors 6. Immune evasion of breast cancer counteracts effective...
mRNA and micro (mi)RNA in breast cancer diagnosis, prognosis and for monitoring response to anticancer therapy. Among these, circulating miRNA is increasingly recognized as a promising biomarker, given the ease with which miRNAs can be isolated and their structural stability under different conditions...